UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)

(Amendment No. 2)*

LEAF GROUP LTD.
(Name of Issuer)

Common Stock, par value $0.0001
(Title of Class of Securities)

52177G102
(CUSIP Number)

Osmium Partners, LLC
300 Drakes Landing Road, Suite 172
Greenbrae, CA 94904
Attention: John H. Lewis
Telephone: (415) 785-4044
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

March 12, 2019
(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [X].
Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent.

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.)


CUSIP No. 52177G102

1.

Names of Reporting Persons.

 

I.R.S. Identification Nos. of above persons (entities only).

   
  

John H. Lewis

2.

Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [   ] (b) [X]

   
3.

SEC Use Only

   
   
4.

Citizenship or Place of Organization

   
 

United States

  5. Sole Voting Power
     
Number of   0
Shares 6. Shared Voting Power
Beneficially    
owned by   1,967,795
Each 7. Sole Dispositive Power
Reporting    
Person   0
With: 8. Shared Dispositive Power
     
    1,967,795
9.

Aggregate Amount Beneficially Owned by Each Reporting Person

   
 

1,967,795 (1)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

   
 

[   ]

11.

Percent of Class Represented by Amount in Row (9)

   
 

7.7 %

12.

Type of Reporting Person (See Instructions)

   
 

IN

(1) Reflects a maximum of 711,700 shares of Common Stock that may be acquired pursuant to options held by the Reporting Persons.


CUSIP No. 52177G102

1.

Names of Reporting Persons.

 

I.R.S. Identification Nos. of above persons (entities only).

   
 

Osmium Partners, LLC

2.

Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [   ] (b) [X]

   
3.

SEC Use Only

   
   
4.

Citizenship or Place of Organization

   
 

Delaware

  5. Sole Voting Power
     
Number of   0
Shares 6. Shared Voting Power
Beneficially    
owned by   1,967,795
Each 7. Sole Dispositive Power
Reporting    
Person   0
With: 8. Shared Dispositive Power
     
    1,967,795
9.

Aggregate Amount Beneficially Owned by Each Reporting Person

   
 

1,967,795 (1)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

   
 

[   ]

11.

Percent of Class Represented by Amount in Row (9)

   
 

7.7 %

12.

Type of Reporting Person (See Instructions)

   
 

IA, OO

(1) Reflects a maximum of 711,700 shares of Common Stock that may be acquired pursuant to options held by the Reporting Persons.


CUSIP No. 52177G102

1.

Names of Reporting Persons.

 

I.R.S. Identification Nos. of above persons (entities only).

   
 

Osmium Capital, LP

2.

Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [   ] (b) [X]

   
3.

SEC Use Only

   
   
4.

Citizenship or Place of Organization

   
 

Delaware

  5. Sole Voting Power
     
Number of   0
Shares 6. Shared Voting Power
Beneficially    
owned by   867,412
Each 7. Sole Dispositive Power
Reporting    
Person   0
With: 8. Shared Dispositive Power
     
    867,412
9.

Aggregate Amount Beneficially Owned by Each Reporting Person

   
 

867,412 (1)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

   
 

[   ]

11.

Percent of Class Represented by Amount in Row (9)

   
 

3.4%

12.

Type of Reporting Person (See Instructions)

   
 

PN

(1) Reflects a maximum of 310,000 shares of Common Stock that may be acquired pursuant to options held by Osmium Capital, LP.


CUSIP No. 52177G102

1.

Names of Reporting Persons.

 

I.R.S. Identification Nos. of above persons (entities only).

   
 

Osmium Capital II, LP

2.

Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [   ] (b) [X]

   
3.

SEC Use Only

   
   
4.

Citizenship or Place of Organization

   
 

Delaware

  5. Sole Voting Power
     
Number of   0
Shares 6. Shared Voting Power
Beneficially    
owned by   370,168
Each 7. Sole Dispositive Power
Reporting    
Person   0
With: 8. Shared Dispositive Power
     
    370,168
9.

Aggregate Amount Beneficially Owned by Each Reporting Person

   
 

370,168 (1)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

   
 

[   ]

11.

Percent of Class Represented by Amount in Row (9)

   
 

1.4 %

12.

Type of Reporting Person (See Instructions)

   
 

PN

(1) Reflects a maximum of 145,000 shares of Common Stock that may be acquired pursuant to options held by Osmium Capital II, LP.


CUSIP No. 52177G102

1.

Names of Reporting Persons.

  

I.R.S. Identification Nos. of above persons (entities only).

   
 

Osmium Spartan, LP

2.

Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [   ] (b) [X]

   
3.

SEC Use Only

   
   
4.

Citizenship or Place of Organization

   
 

Delaware

  5. Sole Voting Power
     
Number of   0
Shares 6. Shared Voting Power
Beneficially    
owned by   321,497
Each 7. Sole Dispositive Power
Reporting    
Person   0
With: 8. Shared Dispositive Power
     
    321,497
9.

Aggregate Amount Beneficially Owned by Each Reporting Person

   
 

321,497 (1)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

   
 

[   ]

11.

Percent of Class Represented by Amount in Row (9)

   
 

1.3%

12.

Type of Reporting Person (See Instructions)

   
 

PN

(1) Reflects a maximum of 115,000 shares of Common Stock that may be acquired pursuant to options held by Osmium Spartan, LP.


CUSIP No. 52177G102

1.

Names of Reporting Persons.

 

I.R.S. Identification Nos. of above persons (entities only).

   
 

Osmium Diamond, LP

2.

Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [   ] (b) [X]

   
3.

SEC Use Only

   
   
4.

Citizenship or Place of Organization

   
 

Delaware

  5. Sole Voting Power
     
Number of   0
Shares 6. Shared Voting Power
Beneficially    
owned by   408,718
Each 7. Sole Dispositive Power
Reporting    
Person   0
With: 8. Shared Dispositive Power
     
    408,718
9.

Aggregate Amount Beneficially Owned by Each Reporting Person

   
 

408,718 (1)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

   
 

[   ]

11.

Percent of Class Represented by Amount in Row (9)

   
 

1.6%

12.

Type of Reporting Person (See Instructions)

   
 

PN

(1) Reflects a maximum of 141,700 shares of Common Stock that may be acquired pursuant to options held by Osmium Diamond, LP.


EXPLANATORY NOTE

This Amendment No. 2 (this “Amendment”) amends and supplements the Schedule 13D filed with the Securities and Exchange Commission on February 4, 2019, as amended on March 4, 2019, by the Reporting Persons (as amended from time to time, the “Schedule 13D”) relating to their beneficial ownership in Leaf Group Ltd. (“Leaf” or the “Issuer”). Except to the extent set forth in this Amendment, all information disclosed in the Schedule 13D remains unchanged. Capitalized terms used but not defined in this Amendment have the respective meanings set forth in the Schedule 13D.

ITEM 4. Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented to add the following:

On March 12, 2019, the Reporting Persons submitted to the Issuer a letter regarding the Reporting Persons’ notice of intention to nominate three individuals—David D. Cathcart, Vladimir S. Jacimovic and Michael J. McConnell (collectively, the “Nominees”)—for election to the Board at the 2019 annual meeting of stockholders of the Issuer. A copy of the letter is attached hereto as Exhibit 3.

ITEM 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

The Reporting Persons entered into an agreement with each of the Nominees (the “Nomination Agreement”) whereby, among other things, each Nominee agreed to become a member of a slate of nominees and stand for election as a director of the Issuer in connection with a proxy solicitation which may be conducted by the Reporting Persons in respect of the 2019 annual meeting of stockholders of the Issuer. Pursuant to the Nomination Agreement, each Nominee confirmed his consent to serve as a director, if nominated, and agreed not to acquire or dispose of any securities of the Issuer without the prior consent of the Reporting Persons. In addition, pursuant to the Nomination Agreement, the Reporting Persons agreed to defend and indemnify each Nominee against, and with respect to, any losses that may be incurred by them in the event they become a party to litigation based on their nomination as candidates for election to the Board or otherwise arising in connection with the solicitation of proxies in support of their election. This description of the Nomination Agreement is qualified in its entirety by reference to the full text of the Nomination Agreement, the form of which is attached hereto as Exhibit 4 and is incorporated by reference herein.

ITEM 7. Material to be Filed as Exhibits.

Item 7 of the Schedule 13D is hereby amended and supplemented to add the following:

Exhibit 3 Letter to Board of Directors, dated March 12, 2019.
   
Exhibit 4 Form of Nomination Agreement.


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated: March 13, 2019

John H. Lewis
Osmium Partners, LLC
Osmium Capital, LP
Osmium Capital II, LP
Osmium Spartan, LP
Osmium Diamond, LP

By: /s/ John H. Lewis
John H. Lewis, for himself and as
Managing Member of Osmium
Partners, LLC, for itself and as
General Partner of Osmium
Capital, LP, Osmium Capital II,
LP and Osmium Spartan, LP

EXHIBIT INDEX

Exhibit 1

Joint Filing Agreement (incorporated by reference to Exhibit 1 to the Schedule 13D filed by John H. Lewis, Osmium Partners, LLC, Osmium Capital, LP, Osmium Capital II, LP, Osmium Spartan, LP and Osmium Diamond, LP on February 4, 2019).

   
Exhibit 2

Letter to Board of Directors, dated March 4, 2019 (incorporated by reference to Exhibit 2 to the Schedule 13D/A filed by John H. Lewis, Osmium Partners, LLC, Osmium Capital, LP, Osmium Capital II, LP, Osmium Spartan, LP and Osmium Diamond, LP on March 4, 2019).

   
Exhibit 3

Letter to Board of Directors, dated March 12, 2019.

   
Exhibit 4

Form of Nomination Agreement.

 



OSMIUM CAPITAL, LP
OSMIUM CAPITAL II, LP
OSMIUM SPARTAN, LP
OSMIUM DIAMOND, LP
c/o OSMIUM PARTNERS, LLC
300 Drakes Landing Road, Suite 172
Greenbrae, California 94904

March 12, 2019

BY FED-EX OVERNIGHT DELIVERY AND EMAIL

Leaf Group Ltd.
1655 26th Street
Santa Monica, CA 90404

Attention: Adam Wergeles, Executive Vice President,
  Legal & General Counsel

Re: Stockholder Nominations for Annual Meeting of the Stockholders of Leaf Group Ltd.

Dear Mr. Wergeles:

            Osmium Capital, LP, a Delaware limited partnership (“ Fund I ”); Osmium Capital II, LP, a Delaware limited partnership (“ Fund II ”); Osmium Spartan, LP, a Delaware limited partnership (“ Fund III ”); Osmium Diamond LP (“ Fund IV ”, and collectively with Fund I, Fund II and Fund III, the “ Funds ”); Osmium Partners, LLC, a Delaware limited liability company (“ Osmium Partners ”); and John H. Lewis, sole Managing Member of Osmium Partners, General Partner of the Funds and a United States citizen (“ Mr. Lewis ”, and collectively with the Funds and Osmium Partners, the “ Nominating Person ”), hereby submits this notice (this “ Notice ”) on the date hereof. The purpose of this Notice, as more fully set forth herein, is to provide notice to Leaf Group Ltd. (the “ Company ”) of the Nominating Person’s intent to nominate three persons for election to the Board of Directors of the Company (the “ Board ”) as directors at the 2019 annual meeting of stockholders of the Company (including any adjournment or postponement thereof or any special meeting held in lieu thereof, the “ Annual Meeting ”).

            This letter and the Exhibits attached hereto are collectively referred to as the “Notice.” As of the date of this Notice, Fund I may be deemed to “beneficially own” (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”)) 867,412 shares of common stock, par value $0.0001 per share, of the Company (the “ Common Stock ”), 100 shares of which are held in record name. Fund II, Fund III and Fund IV may be deemed to beneficially own 370,168 shares of Common Stock, 321,497 shares of Common Stock, and 408,718 shares of Common Stock, respectively. The Nominating Person may be deemed to beneficially own an aggregate of 1,967,795 shares of Common Stock, representing approximately 7.70% of the outstanding shares of Common Stock.


            As of the date hereof, and to the Nominating Person’s knowledge, based on publicly available information, the current Board consists of nine directors who are divided into three classes with staggered three-year terms. At the annual meeting, three of the nine directors are to be elected at the Annual Meeting to serve for a three-year term expiring at the 2022 annual meeting of stockholders. Through this Notice, the Nominating Person hereby nominates, and notifies you of its intent to nominate at the Annual Meeting, David D. Cathcart, Vladimir S. Jacimovic and Michael J. McConnell (each, a “ Nominee ” and together, the “ Nominees ”) for election to the Board. If the Company makes any changes to its Board, nominates individuals not on its current Board, or takes any other action pertinent to the concerns the Participants (as defined below) have expressed about the Company, the Nominating Person reserves the right to amend this Notice, including by substituting and/or increasing the number of its director nominees. Without limiting the generality of the foregoing, if more than three directors are to be elected at the Annual Meeting pursuant to Section 2.5 of the of the Company’s Amended and Restated Bylaws, as adopted on November 9, 2016 (the “ Bylaws ”), the Nominating Person specifically reserves the right to nominate additional persons to be elected and provided that the Nominating Person conforms with Section 2.5 of the Bylaws (each an “ Additional Nominee ”). Additionally, if, due to death or disability or for other good cause, any Nominee or Additional Nominee is unable or unwilling to stand for election at the Annual Meeting, the Nominating Person reserves the right to nominate one or more alternate nominees, as applicable, in place of such Nominee(s) or Additional Nominee(s) (each an “ Alternate Nominee ”). In either event, the Nominating Person will give prompt notice to the Company of its intent to nominate any Additional Nominees or Alternate Nominees at the Annual Meeting. Except where the context otherwise requires, the term “Nominee” as used in this Notice shall be deemed to include one or more Additional Nominees or Alternate Nominees, as applicable. If this Notice shall be deemed for any reason by a court of competent jurisdiction to be ineffective with respect to the nomination of any of the Nominees nominated by the Nominating Person at the Annual Meeting, or if any individual Nominee shall be unable to serve for any reason, this Notice shall continue to be effective with respect to the remaining Nominee(s) and as to any replacement nominee(s) selected by the Nominating Person.

            The Nominating Person intends to solicit proxies in support of the Nominees’ election in accordance with applicable law and intends to comply with applicable requirements of the Exchange Act, and the rules and regulations promulgated thereunder. The manner in which the anticipated solicitation will be undertaken, and information regarding the costs associated therewith and any potential reimbursement, is presently unknown. The participants in this solicitation are anticipated to be: (i) the Funds; (ii) Osmium Partners; (iii) Mr. Lewis and (iv) the Nominees (the entities and individuals listed in this paragraph, each a “ Participant ” and, collectively, the “ Participants ”). It is anticipated that certain regular employees of the Participants will also participate in the solicitation of proxies in support of the Nominees’ election in accordance with applicable law and intends to comply with applicable requirements of the Exchange Act, and the rules and regulations promulgated thereunder. Such employees will receive no additional consideration if they assist in the solicitation of proxies. It is anticipated that proxies will be solicited by mail, courier services, Internet advertising, telephone, facsimile or in person. The Participants intend on retaining the services of a professional services firm for consulting and analytic services and solicitation services in connection with the solicitation of proxies. The terms of such engagement, the anticipated costs involved in the solicitation and the number of employees or other agents to be employed will be finalized only when such firm is engaged. It is anticipated that the costs related to this solicitation of proxies, including expected expenditures for attorneys, accountants, public relations and financial advisors, proxy solicitors, advertising, printing, transportation, litigation and related expenses, will be borne by the Participants. The Participants may seek reimbursement from the Company for such expenses if any of the Nominees are elected.


            Below please find information required by Article II, Section 2.5 of the Bylaws. Information included in any subsection below shall also be deemed to be information provided in response to items requested in any other subsection of this Notice.

A.         Information as to each Nominee:

  1.

The name, age, business and residence address of the Nominee:


Name Age Business Address Residence Address
       
David D. Cathcart 47    
       
Vladimir S. Jacimovic 55    
       
Michael J. McConnell 53    

  2.

The principal occupation or employment of the Nominee:

             David D. Cathcart is the Chief Financial Officer of PricessMiner, Inc., a cloud-based AI solution to minimize variability for manufacturers, a position he has held since 2016. He previously served as the Chief Financial Officer at The North Highland Company, Inc., a global management consulting firm, from April 2014 to January 2016. Prior to joining North Highland, Mr. Cathcart served many roles at TRX, Inc., a travel technology and data services provider and at that time a public company, first joining the company in September 2004 as Controller and later serving as Controller, Chief Financial Officer and Treasurer, Secretary and eventually Chief Executive Officer. Prior to joining TRX, Mr. Cathcart served as Controller of General Electric’s Energy Services Installation and Repair division from September 2003 to September 2004, and Assistant Corporate Controller of Mirant Corporation, an integrator and distributor of electricity generation, from June 2001 to September 2003. Mr. Cathcart earned a B.B.A. in Accountancy from the University of Notre Dame in 1993 and an MBA from the University of Central Florida in 2001, and is a Certified Public Accountant. Mr. Cathcart brings extensive business and strategic expertise, as well as in-depth management experience in public company matters, to our Board. In addition, we believe that Mr. Cathcart’s significant financial and accounting experience with public and private companies makes him a valuable resource to our Board and its committees.

             Vladimir S. Jacimovic is the Founder, Managing General Partner and Managing Partner at Continuum Capital Partners and Continuum Capital Partners Fund, L.P., an investment firm that specializes in crossover investments targeting private and public technology companies. Mr. Jacimovic has over 25 years of investing and operating experience with high growth companies in the technology and services industry with specific expertise in the Software as a Service (SaaS), Big Data and Security segments. Mr. Jacimovic was a Venture Partner at New Enterprise Associates (NEA), a leading global venture capital firm, and a Managing Director at Crosslink Capital, a leading stage-independent venture capital firm. He was an integral part of NEA’s venture growth equity initiative and focused on investments in information technology, including software, communications and technology enabled services, and, while at Crosslink, led or coled over 30 venture and public investments in software, communications and technology enabled services. Since starting his venture career in 1996, Mr. Jacimovic was involved in investments in over 20 companies, including CenterRun, Equinix, Metapath, OnDisplay and Saba Software. He has been a director of 8x8 Inc. since March 2014. Mr. Jacimovic served on the Board of Directors of Phoenix Technologies Ltd., Pentaho Corporation, Compiere, Inc., think3 Inc., AmberPoint, Inc., IMLogic, Inc., newScale LLC, CenterRun, Inc., Xylo Inc., iCopyright, Inc., and Cogit Corporation, among others. Mr. Jacimovic received a B.S. in Computer Science and Mathematics from the University of San Francisco in 1985 and an M.B.A. from Harvard Business School in 1992. We believe Mr. Jacimovic’s qualifications to serve as director include his 25 years of investing and operating experience with high growth companies in the technology and services industry with specific expertise in the SaaS, big data and security segments.


            Michael J. McConnell is a private investor. He has served on the Board of Directors of Adacel Technologies, a developer of operational air traffic management systems, speech recognition applications and advanced air traffic control simulation and training solutions, since 2017, and on the Board of Directors of SPS Commerce, Inc., a provider of cloud-based supply chain management services, since 2018. From April 2016 until the company was sold in September 2017, Mr. McConnell served as a director of Guidance Software Inc., a provider of forensic security and risk management applications. Previously he served as a director of Spark Networks, Inc., a global, on-line dating company, from July 2014 until the then-public company was sold in November 2017, as Chairman of its board from January 2015 until June 2017 and as Interim Executive Chairman and Chief Executive Officer from August 2014 through December 2014. From 2009 to 2012, Mr. McConnell served as the Chief Executive Officer of Collectors Universe, Inc., a provider of third-party authentication and grading of high value collectibles, and served as a director from 2007 to 2013. From 1994 to 2007, Mr. McConnell served as a Managing Director of Shamrock Capital Advisors, an investment manager of domestic and international alternative asset funds, where he was a member of the firm’s Executive Committee. Over the course of his career, Mr. McConnell has served on numerous other public and private company boards in the United States, Australia, New Zealand and Ireland. During the past five years, Mr. McConnell served on the following boards in addition to those listed above: Redflex Holdings Limited, Vitacost Ltd. and PaperlinX Limited. Mr. McConnell received his B.A. in Economics from Harvard University in 1988 and his M.B.A. degree (Shermet Scholar) from the Darden School of the University of Virginia in 1994. We believe that his extensive prior service on both public and private company boards, and considerable experience as an investment professional, makes him a valuable contributor and resource to our Board and its committees.

  3.

The class and number of shares of the Company that are beneficially owned by the Nominee:

            As of the date hereof, neither of Messrs. Cathcart, Jacimovic or McConnell own beneficially or of record any securities of the Company and have not engaged in any transactions in securities of the Company during the past two years.



  4.

All information relating to the Nominee that is required to be disclosed pursuant to Section 2.5(iv)(c) of the Bylaws:

            Except as set forth in this Notice (including the Exhibits hereto), as of the date of this Notice, (i) no Nominee has purchased or sold Synthetic Equity Interests, as defined in the Bylaws; (ii) no Nominee is a party to any proxy, agreement, arrangement, understanding or relationship pursuant to which such Nominee has or shares a right to vote any shares of Common Stock; (iii) no Nominee has purchased or sold Short Interests, as defined in the Bylaws; (iv) no Nominee has a right to dividends on Common Stock owned beneficially by such party that are separated or separable from the underlying shares of the Company; (v) no Nominee is entitled to any performance-related fees (other than an asset-based fee) based on any increase or decrease in the value of Common Stock or any Synthetic Equity Interests or Short Interests, if any; (vi) no Nominee has any material interest in the nomination of directors for election at the Annual Meeting; (vii) no Nominee holds a significant equity interest or any Synthetic Equity Interests or Short Interests in any principal competitor of the Company; (viii) no Nominee holds a direct or indirect interest in any contract with the Company, any affiliate of the Company, or any principal competitor of the Company; (ix) no Nominee is a party to, or material participant in, any pending or threatened litigation involving the Company or any of its officers or directors, or any affiliate of the Company; and (x) no Nominee is a party to any material transaction during the prior twelve (12) months with the Company, any affiliate of the Company or any principal competitor of the Company. Except as set forth in this Notice (including the Exhibits hereto), as of the date of this Notice, no Nominee has been a party to any material discussions regarding the nomination of directors for election at the Annual Meeting.

  5.

All information relating to the Nominee that is required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors in a contested election pursuant to Section 14(a) under the Exchange Act (including such person’s written consent to being named in the proxy statement as a nominee and to serving as a director if elected):

            The Nominating Person believes that each Nominee presently is, and if elected as a director of the Company, each of the Nominees would be, an “independent director” within the meaning of (i) applicable New York Stock Exchange (“NYSE”) listing standards applicable to board composition; (ii) Section 301 of the Sarbanes-Oxley Act of 2002; (iii) the Company’s Corporate Governance Guidelines, as provided on the Company’s website and (iv) paragraph (a)(1) of Item 407 of Regulation S-K under the Securities Act of 1933, as amended (“ Regulation S-K ”). No Nominee is a member of a company’s compensation, nominating or audit committee that is not independent under any such committee’s applicable independence standards.

            All of the Nominees are citizens of the United States of America.

            Each of the Nominees has consented to be named as a Nominee in this Notice, to be named as a Nominee in any proxy statement filed by the Nominating Person or its affiliates in connection with the solicitation of proxies from the Company’s shareholders in connection with the Annual Meeting and to serve as a director of the Company, if so elected (each, a “ Consent ” and collectively, the “ Consents ”). Such Consents are attached hereto as Exhibit A .


            The Nominating Person and certain of its affiliates intend to enter into a Joint Filing and Solicitation Agreement, as necessary, with the Nominees in which, among other things, the parties will agree to (a) the joint filing on behalf of each of them of statements on Schedule 13D, and any amendments thereto, with respect to the securities of the Company and (b) solicit proxies for the election of the Nominees at the Annual Meeting.

            Except as set forth in this Notice (including the Exhibits hereto), as of the date of this Notice, (i) during the past ten years, no Nominee has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); (ii) no Nominee directly or indirectly beneficially owns any securities of the Company; (iii) no Nominee owns any securities of the Company which are owned of record but not beneficially; (iv) no Nominee has purchased or sold any securities of the Company during the past two years; (v) no Nominee or any of his “associates” (which term, for purposes of this Notice, shall have the meaning ascribed thereto in Rule 14a-1 of Regulation 14A of the Exchange Act) is, or was within the past year, a party to any contract, arrangements or understandings with any person with respect to Common Stock, including, but not limited to, joint ventures, loan or option agreements, puts or calls, guarantees against loss or guarantees of profit, division of losses or profit, or the giving or withholding of proxies; (vi) no associate of any Nominee owns beneficially, directly or indirectly, any securities of the Company; (vii) no Nominee owns beneficially, directly or indirectly, any securities of any parent or subsidiary of the Company; (viii) no Nominee or any of his associates was a party to any transaction, or series of similar transactions, since the beginning of the Company’s last fiscal year, or is a party to any currently proposed transaction, or series of similar transactions, to which the Company or any of its subsidiaries was or is to be a party, in which the amount involved exceeds $120,000; (ix) no Nominee or any of his associates has any arrangement or understanding with any person (A) with respect to any future employment by the Company or its affiliates or (B) with respect to any future transactions to which the Company or any of its affiliates will or may be a party; (x) no Nominee has a substantial interest, direct or indirect, by securities holdings or otherwise in any matter to be acted on at the Annual Meeting; (xi) no Nominee holds any positions or offices with the Company; (xii) no Nominee has a family relationship with any director, executive officer, or person nominated or chosen by the Company to become a director or executive officer; and (xiii) no companies or organizations, with which any of the Nominees has been employed in the past five years, is a parent, subsidiary or other affiliate of the Company. There are no material proceedings to which any Nominee or any of his associates is a party adverse to the Company or any of its subsidiaries or has a material interest adverse to the Company or any of its subsidiaries. With respect to each of the Nominees, none of the events enumerated in Item 401(f)(1)-(8) of Regulation S-K of the Exchange Act occurred during the past 10 years. No Nominee nor any of his associates has received any fees earned or paid in cash, stock awards, option awards, non-equity incentive plan compensation, changes in pension value or nonqualified deferred compensation earnings or any other compensation from the Company during the Company’s last completed fiscal year, or is subject to any other compensation arrangement described in Item 402 of Regulation S-K.

            The Nominees have each entered into a nominee agreement (the “Nominee Agreement”) with Osmium Partners pursuant to which Osmium Partners has agreed to pay the costs of soliciting proxies in connection with the Annual Meeting, and to defend and indemnify such Nominees against, and with respect to, any losses that may be incurred by them in the event they become a party to litigation based on their nomination as candidates for election to the Board or otherwise arising in connection with the solicitation of proxies in support of their election. Mr. McConnell is a limited partner in Fund I, whose investment represents 15 basis points of the total capital in the Funds, which the Funds consider to be an immaterial amount in relation to its total capital. Other than this investment, neither the Nominees nor any of their affiliates, associates, or any other persons with whom the Nominee is Acting in Concert (as defined in the Bylaws) have received compensation, direct or indirect, from the Nominating Person, and have not otherwise entered into any material monetary agreements, arrangements or understanding during the past three years with the Nominating Person. The Nominees will not receive any compensation from Osmium Partners for their services as a Nominee or director of the Company, if elected. If elected, the Nominees will be entitled to such compensation from the Company as is consistent with the Company’s practices for services of non-employee directors. A copy of the form of Nominee Agreement between Osmium Partners and each of the Nominees is attached hereto as Exhibit B . Other than the Nominee Agreement, there are no agreements, arrangements or understandings between the Nominating Person and any Nominee or other person(s) pursuant to which the nominations described herein are to be made by the Nominating Person.


            Each of the Nominees has completed a written questionnaire with respect to his background and qualification and a written representation and agreement that such Nominee (A) is not and will not become a party to (x) any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such Nominee, if elected, will act or vote on any issue or question (a “ Voting Commitment ”) that has not been disclosed to the Company or (y) any Voting Commitment that could limit or interfere with such proposed nominee’s ability to comply, if elected as a director of the Company, with such Nominee’s fiduciary duties under applicable law, (B) is not, and will not become a party to, any agreement, arrangement or understanding with any person or entity other than the Company with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director that has not been disclosed to the Company and (C) in such Nominee’s individual capacity and on behalf of the Nominating Person, would be in compliance, if elected as a director of the Company, and will comply with applicable publicly disclosed corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the Company. Such questionnaires are attached hereto as Exhibit C , and such written representations are attached hereto as Exhibit D .

B.         Information as to the Nominating Person:

  1.

A brief description of and the reasons for proposing such matter at the Annual Meeting:

            The Nominating Person intends to seek the election of the Nominees to the Board at the Annual Meeting. The Nominating Person is seeking the election of the Nominees at the Annual Meeting because it believes that the addition of the Nominees to the Board is necessary to help enhance stockholder value at the Company.



  2.

The name and address, as they appear on the Company’s books and records, of the Nominating Person:

            The name and address of the Nominating Person as it appears on its books and records is 300 Drakes Landing Road, Suite 172, Greenbrae, California 94904.

  3.

All information relating to the Nominating Person that is required to be disclosed pursuant to Section 2.5(iv)(a) of the Bylaws:


Name Class Ownership
     
Osmium Capital, LP Common stock, par value $0.0001 per share

867,412 shares of Common Stock owned directly

     
Osmium Capital II, LP Common stock, par value $0.0001 per share

370,168 shares of Common Stock owned directly

     
Osmium Spartan, LP Common stock, par value $0.0001 per share

321,497 shares of Common Stock owned directly

     
Osmium Diamond, LP Common stock, par value $0.0001 per share

408,718 shares of Common Stock owned directly

     
Osmium Partners, LLC Common stock, par value $0.0001 per share

1,967,795 shares of Common Stock owned beneficially (consisting of shares of Common Stock owned directly by Osmium Capital, LP; Osmium Capital II, LP; Osmium Spartan, LP; and Osmium Diamond, LP)

     
John H. Lewis Common stock, par value $0.0001 per share

1,967,795 shares of Common Stock owned beneficially (consisting of shares of Common Stock owned directly by Osmium Capital, LP; Osmium Capital II, LP; Osmium Spartan, LP; and Osmium Diamond, LP)

            The Nominating Person represents that the Funds may be deemed to beneficially own the shares of Common Stock entitled to vote at the Annual Meeting, as noted in the table above, and that Fund I is a holder of record of 100 shares of Common Stock. A representative of the Nominating Person intends to appear in person or by proxy at the Annual Meeting to nominate the Nominees. The securities of the Company beneficially owned by the Funds were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). For information regarding purchases and sales of securities of the Company during the past two years by each of Fund I, Fund II, Fund III and Fund IV, please see Exhibit E .

            Each of Fund I, Fund II, Fund III, Fund IV, Osmium Partners and Mr. Lewis are members of a “group” for purposes of Rule 13d-5(b)(1) of the Exchange Act, may be deemed to beneficially own the securities owned by the other Participants. Each of Fund I, Fund II, Fund III, Fund IV, Osmium Partners and Mr. Lewis specifically disclaims beneficial ownership of the securities disclosed herein that he or it does not directly own. Without limiting the foregoing sentence, each of Fund I, Fund II, Fund III, Fund IV, Osmium Partners, and Mr. Lewis disclaims beneficial ownership with respect to any shares of Common Stock other than the shares owned directly and of record by such individual or entity.


            The principal business of: (i) each of Fund I, Fund II, Fund III and Fund IV is that of a private investment vehicle engaged in investing and trading in a wide variety of securities and financial instruments for its own account; (ii) Osmium Partners is providing investment management services and serving as the general partner of Fund I, Fund II, Fund III and Fund IV; and (iii) Mr. Lewis is serving as the sole Managing Member of Osmium Partners.

  4.

All information relating to the Nominating Person that is required to be disclosed pursuant to Section 2.5(iv)(b) of the Bylaws:

            Except as set forth in this Notice (including the Exhibits hereto), as of the date of this Notice, (i) the Nominating Person has not purchased or sold Synthetic Equity Interests, as defined in the Bylaws; (ii) the Nominating Person is not a party to any proxy, agreement, arrangement, understanding or relationship pursuant to which such Nominating Person has or shares a right to vote any shares of Common Stock; (iii) the Nominating Person has not purchased or sold Short Interests, as defined in the Bylaws; (iv) the Nominating Person does not have a right to dividends on Common Stock owned beneficially by such party that are separated or separable from the underlying shares of the Company; (v) the Nominating Person has no material interest in the nomination of directors for election at the Annual Meeting other than their interests in their capacities as stockholders of the Company; (vi) the Nominating Person does not hold a significant equity interest or any Synthetic Equity Interests or Short Interests in any principal competitor of the Company; (vii) the Nominating Person does not hold a direct or indirect interest in any contract with the Company, any affiliate of the Company, or any principal competitor of the Company; (viii) the Nominating Person is not a party or material participant to any pending or threatened litigation involving the Company or any of its officers or directors, or any affiliates of the Company; (ix) the Nominating Person is not a party to any material transaction during the prior twelve (12) months with the Company, any affiliate of the Company or any principal competitor of the Company; and (x) during the past 10 years, the Nominating Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). There are no material proceedings to which any Nominating Person is a party adverse to the Company or any of its subsidiaries or has a material interest adverse to the Company or any of its subsidiaries.

            Except as otherwise disclosed in this Notice, the Nominating Person is not entitled to any performance-related fees (other than an asset-based fee) based on any increase or decrease in the value of shares of the Company or any Synthetic Equity Interests or Short Interests, if any, as of the date of this Notice. Osmium Partners, as the general partner of each of the Funds, may be entitled to an incentive allocation based on the performance of such entities’ respective portfolio of securities, which includes shares of Common Stock of the Company. Mr. Lewis, as Managing Member of Osmium Partners, the general partner of the Funds, may be deemed to earn a pro-rata portion of any incentive allocation to which Osmium Partners is entitled. Except as set forth in this Notice (including the Exhibits hereto), as of the date of this Notice, the Nominating Person has not been a party to any material discussions regarding the nomination of directors for election at the Annual Meeting.



  5.

Additional information regarding the Participants pursuant to Regulation 14A under the Exchange Act:

            Below is certain additional information with respect to the Participants that is being provided on a supplemental basis. The inclusion of such information in this Notice shall not be deemed to constitute an admission that any such information is required by Article II, Section 2.5 of the Bylaws.

            Except as otherwise set forth in this Notice (including the Exhibits hereto), (i) during the past 10 years, no Participant has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); (ii) no Participant directly or indirectly beneficially owns any securities of the Company; (iii) no Participant owns any securities of the Company which are owned of record but not beneficially; (iv) no Participant has purchased or sold any securities of the Company during the past two years; (v) no part of the purchase price or market value of the securities of the Company owned by any Participant is represented by funds borrowed or otherwise obtained for the purpose of acquiring or holding such securities; (vi) no Participant is, or within the past year was, a party to any contract, arrangements or understandings with any person with respect to any securities of the Company, including, but not limited to, joint ventures, loan or option arrangements, puts or calls, guarantees against loss or guarantees of profit, division of losses or profits, or the giving or withholding of proxies; (vii) no associate of any Participant owns beneficially, directly or indirectly, any securities of the Company; (viii) no Participant owns beneficially, directly or indirectly, any securities of any parent or subsidiary of the Company; (ix) no Participant or any of his or its associates was a party to any transaction, or series of similar transactions, since the beginning of the Company’s last fiscal year, or is a party to any currently proposed transaction, or series of similar transactions, to which the Company or any of its subsidiaries was or is to be a party, in which the amount involved exceeds $120,000; (x) no Participant or any of his or its associates has any arrangement or understanding with any person with respect to any future employment by the Company or its affiliates, or with respect to any future transactions to which the Company or any of its affiliates will or may be a party; (xi) no Participant has a substantial interest, direct or indirect, by securities holdings or otherwise in any matter to be acted on at the Annual Meeting; (xii) no Participant holds any positions or offices with the Company; (xiii) no Participant has a family relationship with any director, executive officer, or person nominated or chosen by the Company to become a director or executive officer; and (xiv) no companies or organizations, with which any of the Participants has been employed in the past five years, is a parent, subsidiary or other affiliate of the Company. There are no material proceedings to which any Participant or any of his or its associates is a party adverse to the Company or any of its subsidiaries or has a material interest adverse to the Company or any of its subsidiaries. With respect to each of the Participants, none of the events enumerated in Item 401(f)(1)-(8) of Regulation S-K of the Exchange Act occurred during the past 10 years.


            The Nominating Person believes that this Notice is sufficient to provide adequate notice and information to the Company regarding the intended nomination of the Nominees and complies with all notification and other requirements applicable to the Company, if any. If, however, you believe that this Notice for any reason does not comply with such requirements or is otherwise insufficient or defective in any respect, the Nominating Person request that you so notify it no later than 12:00 p.m. (Eastern Time) on March 13, 2019 by contacting Murray Indick, Esq. of Morrison & Foerster LLP by telephone at (415) 268-7096. Please be advised that neither the delivery of this Notice nor the delivery of additional information, if any, provided by or on behalf of the Nominating Person or any of the other Participants to the Company from and after the date hereof shall be deemed to constitute (i) an admission by the Nominating Person or any other Participant that this Notice is in any way defective, (ii) an admission as to the legality or enforceability of any particular provision of the Bylaws or any other matter, (iii) a waiver by the Nominating Person or any other Participant of the right to, in any way, contest or challenge the enforceability of any provision of the Bylaws, or of any other matter, or (iv) consent by any Participant to publicly disclose any information contained herein with respect to such Participant.

  Very truly yours,
   
   
  OSMIUM CAPITAL, LP
  OSMIUM CAPITAL II, LP
  OSMIUM SPARTAN, LP
  OSMIUM DIAMOND, LP
  OSMIUM PARTNERS, LLC
  JOHN H. LEWIS

 

  By: /s/ John H. Lewis
    Name:  John H. Lewis
    Title:    Managing Member



Form of Nominee Agreement

PERSONAL AND CONFIDENTIAL
[Nominee]
[Address 1]
[Address 2]

Dear [   ]:

                               This will confirm our understanding as follows:

                               You agree that you are willing, should we so elect, to become a member of a slate of nominees (the “ Slate ”) of an affiliate of the undersigned (the “ Soliciting Party ”), to stand for election as a director of Leaf Group Ltd., a Delaware corporation (the “ Company ”) in connection with a proxy solicitation (the “ Proxy Solicitation ”) to be conducted by the undersigned and certain other parties, or appointment or election by other means. You further agree to serve as a director of the Company if so elected or appointed. The undersigned agrees on behalf of the Soliciting Party to pay the costs of the Proxy Solicitation.

                               You understand that it may be difficult, and perhaps impossible, to replace a nominee who has agreed to serve on the Slate and, if elected, as a director of the Company if such nominee later changes his mind and determines not to serve on the Slate or, if elected, as a director of the Company. Accordingly, the undersigned is relying upon your agreement to serve on the Slate and, if elected, as a director of the Company. In that regard, you are being supplied with a questionnaire (the “ Questionnaire ”) in which you will provide the undersigned with information necessary for the Soliciting Party to make appropriate disclosure to the Company and to use in creating the Proxy Solicitation materials to be sent to shareholders of the Company and filed with the Securities and Exchange Commission in connection with the Proxy Solicitation.

                               You agree that (i) you will promptly complete, execute and return the Questionnaire, (ii) your responses in the Questionnaire will be true, complete and correct in all respects, and (iii) you will provide any additional information as may be requested by the undersigned. In addition, you agree that, concurrently with your execution of this letter, you will execute and return the enclosed instrument confirming that you consent to being nominated for election as a director of the Company and, if elected, consent to serving as a director of the Company. Upon being notified that we have chosen you, we may forward your consent and your completed Questionnaire (or summary thereof) to the Company, and we may at any time, in our discretion, disclose such information, as well as the existence and contents of this letter. Furthermore, you understand that we may elect, at our expense, to conduct a background and reference check on you and you agree to complete and execute any necessary authorization forms or other documents required in connection therewith.

                               You further agree that (w) you will treat confidentially all information relating to the Proxy Solicitation which is non-public, confidential or proprietary in nature; (x) neither you nor any of your affiliates will acquire or dispose of any securities of the Company without the prior approval of the undersigned, which approval shall not be unreasonably withheld or delayed; (y) you will not issue, publish or otherwise make any public statement or any other form of communication relating to the Company or the Proxy Solicitation without the prior approval of the undersigned; and (z) you will not agree to serve, or agree to be nominated to stand for election by the Company or any other shareholder of the Company (other than the undersigned), as a director of the Company without the prior approval of the undersigned.


                               The undersigned agrees on behalf of the Soliciting Party that the undersigned will defend, indemnify and hold you harmless from and against any and all losses, claims, damages, penalties, judgments, awards, settlements, liabilities, costs, expenses and disbursements (including, without limitation, reasonable attorneys’ fees, costs, expenses and disbursements) incurred by you in the event that you become a party, or are threatened to be made a party, to any civil, criminal, administrative or arbitrative action, suit or proceeding, and any appeal thereof, (i) relating to your role as a nominee for director of the Company on the Slate, or (ii) otherwise arising from or in connection with or relating to the Proxy Solicitation. Your right of indemnification hereunder shall continue after the delivery of proxies to the Company pursuant to the Proxy Solicitation (the “ Delivery ”) has taken place but only for events that occurred prior to the Delivery and subsequent to the date hereof. Anything to the contrary herein notwithstanding, the undersigned is not indemnifying you for any action taken by you or on your behalf that occurs prior to the date hereof or subsequent to the conclusion of the Proxy Solicitation or such earlier time as you are no longer a nominee on the Slate or for any actions taken by you as a director of the Company, if you are so elected or appointed.

                               Nothing herein shall be construed to provide you with indemnification (i) if you are found to have engaged in a violation of any provision of state or federal law in connection with the Proxy Solicitation, unless you demonstrate that your action was taken in good faith and in a manner you reasonably believed to be in or not opposed to the best interests of electing the Slate; (ii) if you acted in a manner that constitutes gross negligence or willful misconduct; or (iii) if you provided false or misleading information, or omitted material information, in the Questionnaire or otherwise in connection with the Proxy Solicitation. You shall promptly notify the undersigned in writing in the event of any third-party claims actually made against you or known by you to be threatened if you intend to seek indemnification hereunder in respect of such claims. In addition, upon your delivery of notice with respect to any such claim, the undersigned shall have the option, at any time, to assume control of the defense of such claim with counsel chosen by the undersigned. The undersigned shall not be responsible for any settlement of any claim against you covered by this indemnity without its prior written consent. However, the undersigned may not enter into any settlement of any such claim without your consent unless such settlement includes (i) no admission of liability or guilt by you and (ii) a release of you from any and all liability in respect of such claim.

                               Each of us recognizes that should you be elected to the Board of Directors of the Company all of your activities and decisions as a director will be governed by applicable law and subject to your fiduciary duties, as applicable, to the Company and to the shareholders of the Company and, as a result, that there is, and can be, no agreement between you and the undersigned that governs the decisions which you will make as a director of the Company.


                               This agreement shall automatically terminate on the earliest to occur of (x) the conclusion of the Company’s next annual meeting of shareholders (regardless of the outcome), (y) your election or appointment to the Board of Directors of the Company or (z) our communication to you of our intent not to proceed with the Proxy Solicitation.

                               This letter sets forth the entire agreement between the undersigned and you as to the subject matter contained herein, and cannot be amended, modified or terminated except by a writing executed by the undersigned and you. This letter shall be governed by the laws of the State of New York, without giving effect to principles of conflicts of law.

                               Should the foregoing agree with your understanding, please so indicate in the space provided below, whereupon this letter will become a binding agreement between us.

                                   Sincerely yours,
   
  OSMIUM PARTNERS, LLC

  By: _______________________________________________
   
                           John H. Lewis
                           Managing Member

Agreed to and Accepted
                 as of the date set forth above:

     By: _______________________________________________

Name: